Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Donald Trump

This page shows the latest Donald Trump news and features for those working in and with pharma, biotech and healthcare.

UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains

UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains

Remdesivir has been touted as a potential treatment for COVID-19 since the early days of the pandemic, with the drug recently being administered to US president Donald Trump after he

Latest news

More from news
Approximately 7 fully matching, plus 61 partially matching documents found.

Latest Intelligence

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Other antivirals including hydroxychloroquine – a drug championed by President Donald Trump – and favipiravir are also in clinical development, raising hopes that researchers will find a drug with some level of efficacy

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    A standard malaria treatment: chloroquine and hydroxychloroquine. A decades-old antimalaria drug, chloroquine, entered the global spotlight in March after US President Donald Trump touted it as a potentially effective coronavirus

  • The rise of CEO activism The rise of CEO activism

    In 2018, Merck CEO Kenneth Frazier famously resigned from Donald Trump’s business advisory council after Trump failed to condemn neo-Nazi protests in Charlottesville. ... Frazier took to Twitter to make his stand and, within an hour, Trump responded by

  • Pharmaceutical social media after Cambridge Analytica Pharmaceutical social media after Cambridge Analytica

    and Donald Trump’s election campaign, or Christopher Wylie, the ‘whistleblower’ and data scientist whose idea at the age of 24 had led to the foundation of Cambridge Analytica. ... Evidence presented to the House of Commons Committee showed that

  • Pharma deals continue to slide Pharma deals continue to slide

    Little did US electors know what would be the effect on the US biopharma industry and its deals when they elected Donald Trump. ... Similarly, the Euro is now around 10% stronger against the dollar since President Trump was inaugurated.

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Origins - The Patient Focused Specialists

Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value...

Latest intelligence

The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...

Quick links